The information in this prospectus is not complete and may be changed. Neither we northe selling securityholders may sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buythese securities in any jurisdiction where the offer or sale is not permitted.
Subject to completion, dated January 19, 2022
PRELIMINARY PROSPECTUS
Ermenegildo ZegnaN.V.
Up to 231,802,500 Ordinary Shares
Up to 20,116,667 Ordinary Shares Issuable Upon Exercise of Warrants
Up to 6,700,000 Warrants
This prospectus relates to theissuance by us of up to 20,116,667 of our ordinary shares, nominal value 0.02 per share (Ordinary Shares), which include up to (i) 6,700,000 Ordinary Shares issuable upon the exercise of 6,700,000 private placement warrants(the Private Placement Warrants) originally issued by Zegna in a private placement transaction in connection with the Business Combination (as defined below) at an exercise price of $11.50 per Ordinary Share, and (ii) 13,416,667Ordinary Shares issuable upon the exercise of 13,416,667 warrants (the Public Warrants and, together with the Private Placement Warrants, the Warrants) originally issued to public shareholders ofInvestindustrial Acquisition Corp. (IIAC) in its initial public offering, and converted into warrants to purchase Ordinary Shares at the closing of the Business Combination at an exercise price of $11.50 per Ordinary Share.
This prospectus also relates to the offer and sale from time to time by the selling securityholders or their permitted transferees (collectively, theselling securityholders) of (a) up to 231,802,500 Ordinary Shares (including (i) up to 37,140,000 Ordinary Shares issued to certain selling securityholders concurrently with the closing of the business combination (theBusiness Combination) between us and Investindustrial Acquisition Corp., a Cayman Islands exempted company, (ii) up to 6,700,000 Ordinary Shares issuable upon exercise of our private placement warrants, and (iii) up to187,962,500 Ordinary Shares currently held by certain selling shareholders) and (b) up to 6,700,000 of our private placement warrants.
This prospectusalso covers any additional securities that may become issuable by reason of share splits, share dividends or other similar transactions.
We are registeringthe offer and sale of the securities described above to satisfy certain registration rights we have granted. We are registering these securities for resale by the selling securityholders named in this prospectus, or their transferees, pledgees,donees or assignees or other successors-in-interest that receive any of the shares as a gift, distribution, or other non-salerelated transfer. The selling securityholders may offer all or part of the securities for resale from time to time through public or private transactions, at either prevailing market prices or at privately negotiated prices. These securities arebeing registered to permit the selling securityholders to sell securities from time to time, in amounts, at prices and on terms determined at the time of offering. The selling securityholders may sell these securities through ordinary brokeragetransactions, directly to market makers of our shares or through any other means described in the section titled Plan of Distribution. In connection with any sales of the securities offered hereunder, the selling securityholders,any underwriters, agents, brokers or dealers participating in such sales may be deemed to be underwriters within the meaning of the Securities Act of 1933, as amended.
All of the Ordinary Shares and Warrants offered by the selling securityholders pursuant to this prospectus will be sold by the selling securityholders for theirrespective accounts. We will not receive any of the proceeds from the sale of Ordinary Shares or Warrants by the selling securityhoderls or the issuance of Ordinary Shares by us pursuant to this prospectus, except with respect to amounts received byus upon exercise of the Warrants.
We will pay certain expenses associated with the registration of the securities covered by this prospectus, as describedin the section titled Plan of Distribution.
The Ordinary Shares and our Public Warrants are listed on the New York Stock Exchange(NYSE) under the symbols ZGN and ZGN WS, respectively. On January 14, 2022, the closing sale price as reported on NYSE of the Ordinary Shares was $9.75 per share and of our Public Warrants was $1.87per Public Warrant.
We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read thisentire prospectus and any amendments or supplements carefully before you make your investment decision.
Our principal executive offices are located atViale Roma 99/100, 13835 Valdilana loc. Trivero, Italy.
Investing in our securitiesinvolves a high degree of risk. Before buying any securities, you should carefully read the discussion of material risks of investing in our securities in Risk Factors beginning on page 14of this prospectus.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of thesesecurities or passed on the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
Prospectusdated , 2022